Literature DB >> 23519562

Increased invasiveness of osteosarcoma mesenchymal stem cells induced by bone-morphogenetic protein-2.

Xiao Yang1, Ya-ping Wang, Feng-xiang Liu, Ke Zeng, Ming-quan Qian, Gang Chen, Lei Shi, Guo-xing Zhu.   

Abstract

To evaluate the different traits of mesenchymal stem cell (MSC) isolated from osteosarcoma (OS) and normal bone marrow (BM) induced by bone-morphogenetic protein-2 (BMP-2). MSCs from implanted osteosarcoma or femur bone marrow were isolated and cultured. Differentiation potency was verified and phenotypes were evaluated by flow cytometry. Increased or decreased expressions of BMP-2 were delivered by adenovirus and lentivirus vector, respectively. Expressions of VEGF, EMMPRIN, and MMP-9 were examined. Cell cycle, apoptosis, invasiveness, and proliferation assays were performed between the transfected groups and controls. Increased BMP-2 induced over-expression of VEGF, EMMPRIN, and MMP-9 in OS- and BM-MSCs both intra- and extra-cellularly. Decreased BMP-2 expression induced inhibition of the factors. Increased BMP-2 also induced less population of cells at G1 phase, more apoptotic cells, more cells that invade through Transwell membrane, and faster proliferation in OSMSC compared to those in BMMSC. BMP-2 induced higher expression of tumorigenic factors, which could be responsible for promoting the proliferation and aggressiveness of OSMSC over BMMSC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23519562     DOI: 10.1007/s11626-013-9598-0

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  39 in total

1.  Targeted mRNA degradation by double-stranded RNA in vitro.

Authors:  T Tuschl; P D Zamore; R Lehmann; D P Bartel; P A Sharp
Journal:  Genes Dev       Date:  1999-12-15       Impact factor: 11.361

2.  Embryonic stem cells. Stem cells not so stealthy after all.

Authors:  Gretchen Vogel
Journal:  Science       Date:  2002-07-12       Impact factor: 47.728

Review 3.  Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture.

Authors:  L A Liotta
Journal:  Cancer Res       Date:  1986-01       Impact factor: 12.701

4.  Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer.

Authors:  Y Takahashi; S L Tucker; Y Kitadai; A N Koura; C D Bucana; K R Cleary; L M Ellis
Journal:  Arch Surg       Date:  1997-05

5.  Role of vascular endothelial growth factor as a tumour marker in osteosarcoma: a prospective study.

Authors:  Shishir Rastogi; Ramakant Kumar; Sukesh Rao Sankineani; Kanniraj Marimuthu; Laxman Rijal; Shyam Prakash; Divesh Jalan; Shah Alam Khan; Mehar C Sharma
Journal:  Int Orthop       Date:  2012-09-27       Impact factor: 3.075

Review 6.  Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.

Authors:  Daniel J Hicklin; Lee M Ellis
Journal:  J Clin Oncol       Date:  2004-12-07       Impact factor: 44.544

7.  Survival in high-grade osteosarcoma: improvement over 21 years at a single institution.

Authors:  P Picci; M Mercuri; S Ferrari; M Alberghini; A Briccoli; C Ferrari; E Pignotti; G Bacci
Journal:  Ann Oncol       Date:  2009-11-04       Impact factor: 32.976

8.  Effects of resveratrol on vascular endothelial growth factor expression in osteosarcoma cells and cell proliferation.

Authors:  Zhonghe Liu; Yanlan Li; Rui Yang
Journal:  Oncol Lett       Date:  2012-07-25       Impact factor: 2.967

9.  Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases.

Authors:  Haixia Cheng; Tsuyoshi Fukushima; Nobuyasu Takahashi; Hiroyuki Tanaka; Hiroaki Kataoka
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

10.  Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization.

Authors:  Lindolfo da Silva Meirelles; Nance Beyer Nardi
Journal:  Br J Haematol       Date:  2003-11       Impact factor: 6.998

View more
  9 in total

Review 1.  Targeting cancer stem cell pathways for cancer therapy.

Authors:  Liqun Yang; Pengfei Shi; Gaichao Zhao; Jie Xu; Wen Peng; Jiayi Zhang; Guanghui Zhang; Xiaowen Wang; Zhen Dong; Fei Chen; Hongjuan Cui
Journal:  Signal Transduct Target Ther       Date:  2020-02-07

Review 2.  When 1+1>2: Nanostructured composites for hard tissue engineering applications.

Authors:  Vuk Uskoković
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2015-08-01       Impact factor: 7.328

3.  Inhibition of mTOR and HIF pathways diminishes chondro-osteogenesis and cell proliferation in chondroblastoma.

Authors:  Xiao Yang; Zheng-jie Yang; Feng-xiang Liu; Ke Zeng; Ming-quan Qian; Gang Chen; Lei Shi; Guo-xing Zhu
Journal:  Tumour Biol       Date:  2013-06-13

Review 4.  Bone morphogenetic protein signaling in musculoskeletal cancer.

Authors:  Myrto Bami; Andreas F Mavrogenis; Andrea Angelini; Mandy Milonaki; Evanthia Mitsiokapa; Dimitrios Stamoulis; Panayotis N Soucacos
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-04       Impact factor: 4.553

5.  CORR Insights®: Is Use of BMP-2 Associated with Tumor Growth and Osteoblastic Differentiation in Murine Models of Osteosarcoma?

Authors:  Terri A Zachos
Journal:  Clin Orthop Relat Res       Date:  2020-12       Impact factor: 4.755

Review 6.  Biomaterial-based strategies for maxillofacial tumour therapy and bone defect regeneration.

Authors:  Bowen Tan; Quan Tang; Yongjin Zhong; Yali Wei; Linfeng He; Yanting Wu; Jiabao Wu; Jinfeng Liao
Journal:  Int J Oral Sci       Date:  2021-03-16       Impact factor: 6.344

7.  Calcium Phosphate as a Key Material for Socially Responsible Tissue Engineering.

Authors:  Vuk Uskoković; Victoria M Wu
Journal:  Materials (Basel)       Date:  2016-06-01       Impact factor: 3.623

8.  TSSC3 represses self-renewal of osteosarcoma stem cells and Nanog expression by inhibiting the Src/Akt pathway.

Authors:  Guang-Ning Yan; Xue-Feng Tang; Xian-Chao Zhang; Ting He; Yu-Sheng Huang; Xi Zhang; Gang Meng; De-Yu Guo; Yang-Fan Lv; Qiao-Nan Guo
Journal:  Oncotarget       Date:  2017-08-24

Review 9.  Targeting cancer stem cell pathways for cancer therapy.

Authors:  Liqun Yang; Pengfei Shi; Gaichao Zhao; Jie Xu; Wen Peng; Jiayi Zhang; Guanghui Zhang; Xiaowen Wang; Zhen Dong; Fei Chen; Hongjuan Cui
Journal:  Signal Transduct Target Ther       Date:  2020-02-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.